NCT05296317 2026-02-19
EMEG-ECDD
Centre Georges Francois Leclerc
Phase NA Completed
Clinical Trials
8 trialsNCT02961257 2022-05-12
CABASTY
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
Phase 3 Completed
NCT01180322 2020-12-31
azacitidine
University of Ulm
Phase 2 Completed
NCT02319135 2020-04-06
FLUGAZA
PETHEMA Foundation
Phase 3 Completed
NCT01985724 2014-05-14
Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer
Hellenic Oncology Research Group
Phase 3 Completed
NCT00379574 2013-03-15
Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL
Asan Medical Center
Phase 1/2 Completed
NCT01107756 2012-10-05
Grano-Tax
Sanofi
Phase 4 Completed
NCT01085058 2010-03-11
CU01
WiSP Wissenschaftlicher Service Pharma GmbH
Phase 2/3 Completed